Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report

ConclusionNeoadjuvant crizotinib therapy may be effective for large, locally advanced, and difficult to resect tumors.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research